These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 34144129)
1. Mesenchymal stem cells in glioblastoma therapy and progression: How one cell does it all. Nowak B; Rogujski P; Janowski M; Lukomska B; Andrzejewska A Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188582. PubMed ID: 34144129 [TBL] [Abstract][Full Text] [Related]
3. Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies. Bajetto A; Thellung S; Dellacasagrande I; Pagano A; Barbieri F; Florio T Stem Cells Transl Med; 2020 Nov; 9(11):1310-1330. PubMed ID: 32543030 [TBL] [Abstract][Full Text] [Related]
4. The potential of mesenchymal stem cell coexpressing cytosine deaminase and secretory IL18-FC chimeric cytokine in suppressing glioblastoma recurrence. Taheri M; Tehrani HA; Farzad SA; Korourian A; Arefian E; Ramezani M Int Immunopharmacol; 2024 Dec; 142(Pt A):113048. PubMed ID: 39236459 [TBL] [Abstract][Full Text] [Related]
5. Simultaneous impact of atorvastatin and mesenchymal stem cells for glioblastoma multiform suppression in rat glioblastoma multiform model. Goodarzi A; Khanmohammadi M; Ai A; Khodayari H; Ai A; Farahani MS; Khodayari S; Ebrahimi-Barough S; Mohandesnezhad S; Ai J Mol Biol Rep; 2020 Oct; 47(10):7783-7795. PubMed ID: 32981013 [TBL] [Abstract][Full Text] [Related]
6. Effects of tumor treating fields (TTFields) on human mesenchymal stromal cells. Strack M; Kückelhaus J; Diebold M; Wuchter P; Huber PE; Schnell O; Sankowski R; Prinz M; Grosu AL; Heiland DH; Nicolay NH; Rühle A J Neurooncol; 2024 Sep; 169(2):329-340. PubMed ID: 38900237 [TBL] [Abstract][Full Text] [Related]
7. Tropism of mesenchymal stem cell toward CD133 Pavon LF; Sibov TT; de Souza AV; da Cruz EF; Malheiros SMF; Cabral FR; de Souza JG; Boufleur P; de Oliveira DM; de Toledo SRC; Marti LC; Malheiros JM; Paiva FF; Tannús A; de Oliveira SM; Chudzinski-Tavassi AM; de Paiva Neto MA; Cavalheiro S Stem Cell Res Ther; 2018 Nov; 9(1):310. PubMed ID: 30413179 [TBL] [Abstract][Full Text] [Related]
8. Exploiting tumor-intrinsic signals to induce mesenchymal stem cell-mediated suicide gene therapy to fight malignant glioma. Li M; Sun S; Dangelmajer S; Zhang Q; Wang J; Hu F; Dong F; Kahlert UD; Zhu M; Lei T Stem Cell Res Ther; 2019 Mar; 10(1):88. PubMed ID: 30867058 [TBL] [Abstract][Full Text] [Related]
9. Glioma-associated mesenchymal stem cells-mediated PD-L1 expression is attenuated by Ad5-Ki67/IL-15 in GBM treatment. Zhang Q; Zhang J; Wang P; Zhu G; Jin G; Liu F Stem Cell Res Ther; 2022 Jun; 13(1):284. PubMed ID: 35765095 [TBL] [Abstract][Full Text] [Related]
10. Reverted effect of mesenchymal stem cells in glioblastoma treated with agathisflavone and its selective antitumoral effect on cell viability, migration, and differentiation via STAT3. Nascimento RP; Dos Santos BL; da Silva KC; Amaral da Silva VD; de Fátima Costa M; David JM; David JP; Moura-Neto V; Oliveira MDN; Ulrich H; de Faria Lopes GP; Costa SL J Cell Physiol; 2021 Jul; 236(7):5022-5035. PubMed ID: 33368262 [TBL] [Abstract][Full Text] [Related]
11. Cytokines play a key role in communication between mesenchymal stem cells and brain cancer cells. Motaln H; Turnsek TL Protein Pept Lett; 2015; 22(4):322-31. PubMed ID: 25642990 [TBL] [Abstract][Full Text] [Related]
12. High Adenosine Extracellular Levels Induce Glioblastoma Aggressive Traits Modulating the Mesenchymal Stromal Cell Secretome. Pietrobono D; Giacomelli C; Marchetti L; Martini C; Trincavelli ML Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081024 [TBL] [Abstract][Full Text] [Related]
13. Local Intracerebral Immunomodulation Using Interleukin-Expressing Mesenchymal Stem Cells in Glioblastoma. Mohme M; Maire CL; Geumann U; Schliffke S; Dührsen L; Fita K; Akyüz N; Binder M; Westphal M; Guenther C; Lamszus K; Hermann FG; Schmidt NO Clin Cancer Res; 2020 Jun; 26(11):2626-2639. PubMed ID: 31988196 [TBL] [Abstract][Full Text] [Related]
14. Novel insights into astrocyte-mediated signaling of proliferation, invasion and tumor immune microenvironment in glioblastoma. Zhang H; Zhou Y; Cui B; Liu Z; Shen H Biomed Pharmacother; 2020 Jun; 126():110086. PubMed ID: 32172060 [TBL] [Abstract][Full Text] [Related]
15. Polylysine-modified polyethylenimine polymer can generate genetically engineered mesenchymal stem cells for combinational suicidal gene therapy in glioblastoma. Malik YS; Sheikh MA; Xing Z; Guo Z; Zhu X; Tian H; Chen X Acta Biomater; 2018 Oct; 80():144-153. PubMed ID: 30223091 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal stem cell-glioblastoma interactions mediated via kinin receptors unveiled by cytometry. Pillat MM; Oliveira-Giacomelli Á; das Neves Oliveira M; Andrejew R; Turrini N; Baranova J; Lah Turnšek T; Ulrich H Cytometry A; 2021 Feb; 99(2):152-163. PubMed ID: 33438373 [TBL] [Abstract][Full Text] [Related]
17. Human mesenchymal stem cells and their paracrine factors for the treatment of brain tumors. Chan JK; Lam PY Cancer Gene Ther; 2013 Oct; 20(10):539-43. PubMed ID: 24052128 [TBL] [Abstract][Full Text] [Related]
18. Human Glioblastoma-Derived Mesenchymal Stem Cell to Pericytes Transition and Angiogenic Capacity in Glioblastoma Microenvironment. Yi D; Xiang W; Zhang Q; Cen Y; Su Q; Zhang F; Lu Y; Zhao H; Fu P Cell Physiol Biochem; 2018; 46(1):279-290. PubMed ID: 29590646 [TBL] [Abstract][Full Text] [Related]
19. MiR-146b-5p suppresses the malignancy of GSC/MSC fusion cells by targeting SMARCA5. Wang H; Tan L; Dong X; Liu L; Jiang Q; Li H; Shi J; Yang X; Dai X; Qian Z; Dong J Aging (Albany NY); 2020 Jul; 12(13):13647-13667. PubMed ID: 32632040 [TBL] [Abstract][Full Text] [Related]